arrow
C

Carsten Flohr

guy's and st thomas' nhs foundation trust
H指数:69
被引数:3.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Work impact of immune-mediated inflammatory skin diseases: A systematic review and meta-analysis

免疫介导性炎症性皮肤病的劳动力影响:一项系统评价和荟萃分析

2026-08-110
PRE
Targeted therapies for psoriasis and atopic dermatitis in the context of malignancy: SPIN-FRT recommendations

针对银屑病和特应性皮炎的靶向治疗在恶性肿瘤背景下的应用:SPIN-FRT建议

2026-08-110
PRE
P149 Efficacy of lebrikizumab at 16 weeks: pooled analyses from the ADvocate1 and ADvocate2 phase III trials in adolescent and older adult patients with moderate-to-severe atopic dermatitis

P149 青少年和成年中重度特应性皮炎患者中lebrikizumab 16周疗效:ADvocate1和ADvocate2 III期试验的合并分析

2026-06-260
OAAI
P127 Impact of minimal disease activity on quality of life in patients with atopic eczema: results from the UK-Irish Atopic eczema Systemic TherApy Register (A-STAR)

P127 最小疾病活动度对特应性湿疹患者生活质量的影响:来自英国-爱尔兰特应性湿疹系统性治疗登记系统(A-STAR)的结果

2026-06-260
OAAI
Decentralised clinical trials of investigational medicinal products

investigational medicinal products的分散式临床试验

2026-04-160
OAAI
Associations between early-life exposures and the infant skin microbiome

早期生活暴露与婴儿皮肤微生物组的关联

2026-04-010
PRE
International Multi-Center Case Series of Gestational Dupilumab Exposure in the Treatment of Atopic Dermatitis: Maternal Complications and Fetal Outcomes

国际多中心病例系列研究:妊娠期Dupilumab暴露于特应性皮炎治疗中的母体并发症和胎儿结局

2025-10-290
PRE
Grand challenges for skin health revisited: the International League of Dermatological Societies skin disease atlases

皮肤健康的重大挑战再探:国际皮肤科学会联盟皮肤疾病图集

2025-10-010
OAAI
Drug survival of systemic treatments for severe paediatric psoriasis: An international retrospective study

重度儿童银屑病系统性治疗药物的生存率:一项国际回顾性研究

2025-10-010
PRE
Skin disease in the Eastern Cape (SKINSCAPE): a Global Psoriasis Atlas point prevalence study in rural South Africa

东开普省皮肤疾病(SKINSCAPE):南非农村地区全球银屑病地图册横断面研究

2025-10-010
OAAI